Responsabilidad social, marketing e industria farmacéutica: a propósito del informe Mental Health and Integration

• Miguel Valverde Eizaguirre ^[1] ; José Inchauspe Aróstegui ^[2]
  1. [1] Gobierno de Navarra

     Gobierno de Navarra

     Pamplona, España

     
  2. [2] Centro de Salud Mental de San Juan. Servicio Navarro de Salud
• Localización: Revista de la Asociación Española de Neuropsiquiatría, ISSN 0211-5735, Vol. 35, Nº. 127, 2015, págs. 619-631
• Idioma: español
• DOI: 10.4321/s0211-57352015000300012
• Títulos paralelos:
  • Social responsibility, marketing and pharmaceutical industry: in relation with the report on Mental Health and Integration
• Enlaces
  • Texto completo
• Dialnet Métricas: 1 Cita
• Referencias bibliográficas
  • (1) The Economist Intelligence Unit “Mental Health and Integration. Provision for supporting people with mental illness: a comparison of 30...
  • (2) Time to Change [Consultado 13-1-2015] Disponible en: http://www.time-to-change. org.uk/
  • (3) Van Veldhuizen JR, Bahler M. “Manual Flexible ACT Vision, model, practice and organization” Groningen, 2013.
  • (4) Individual Placement and Support. [Consultado 13-1-2015] Disponible en: http:// waamh.org.au/development-and-training/individual-placement--support-ips.aspx
  • (5) EUFAMI. Prospect. [Consultado 13-1-2015] Disponible en: http://www.eufami.org/ resources-services/prospect
  • (6) Patient Reported Outcome Measures. [Consultado 13-1-2015] Disponible en: http:// www.hscic.gov.uk/proms
  • (7) Outcomes Star. Mental Health Recovery Star™ [Consultado 13-1-2015] Disponible en: http://www.outcomesstar.org.uk/mental-health/
  • (8) ROAMER A roadmap for mental health research in Europe. [Consultado 13-1-2015] Disponible en: http://www.roamer-mh.org/
  • (9) Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders...
  • (10) Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. European...
  • (11) Thornicroft G, Rose D, Mehta N. Discrimination against people with mental illness: what can psychiatrists do? Advances in psychiatric...
  • (12) Mack S, Jacobi F, Gerschler A, Strehle J, Hofler M, Busch MA, et al.Self-reported utilization of mental health services in the adult...
  • (13) Mauer B. Morbidity and Mortality in People with Serious Mental Illness. National Association of State Mental Health Program Directors...
  • (14) Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, et al. What is the impact of mental health-related stigma...
  • (15) Rosen A, Mueser KT, Teesson M. Assertive community treatment—Issues from scientific and clinical literature with implications for practice....
  • (16) Whitaker R. Rethinking Psychiatric Care History, Science, and the Long-term Effects of Psychiatric Drugs. Presentación 2013. [Consultado...
  • (17) Whitaker R. Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America EEUU: Broadway...
  • (18) Bentall R.P. Medicalizar la mente ¿Sirven de algo los tratamientos psiquiátricos? Barcelona: Herder, 2011.
  • (19) Moncrieff, J. The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment. UK: Palgrave Macmillan, 2009.
  • (20) Jackson, G.E. Drug-Induced Dementia: a perfect crime. EEUU: AuthorHouse, 2009. (1) Davies, J. Cracked: The Unhappy Truth about Psychiatry....
  • (21) Gotzsche, P. La psiquiatría se hunde (traducción) (2014). [Consultado 13-1-2015] Disponible en: http://www.nogracias.eu/2014/08/10/la-psiquiatria-se-hunde/
  • (22) Coles S, Keenan S, Diamond B. Madness Contested: Power and Practice. UK: PCCS Books, 2013
  • (23) Maturo A. Bipolar disorder and the medicalization of mood: an epidemics of diagnosis? en Mukherjea, A. (editor) Understanding emerging...
  • (24) Valverde MA. El arte de hacer visible lo invisible: el marketing en el TDAH. (2015). Aceptado para publicación en NORTE de Salud Mental.